Who Controls Medical AI and What Do They Want?
In this episode, Dr. Eric Topol discusses the promise and pitfalls of medical AI, highlighting how nearly 1,000 FDA‑approved AI tools exist but are rarely used in routine care, while millions turn to unregulated chatbots for health advice. He explains that AI can improve disease detection—citing a 29% boost in cancer detection—and enable decades‑early risk prediction for major age‑related illnesses, yet institutional inertia, reimbursement challenges, and profit‑driven control by insurers, tech firms, and hospital administrators hinder adoption. Topol warns that without careful governance, AI could become another revenue‑focused tool like electronic health records, exacerbating inequities, but he also points to successful implementations in places like China that demonstrate AI’s potential to enhance prevention and restore clinician‑patient time.
Will AI Help You Live 50 More Years? Immunologist Derya Unutmaz Weighs In
In this episode, NIH‑funded immunologist Derya Unutmaz discusses his bold predictions that AI will usher in a "biosingularity"—a convergence of artificial intelligence and biotechnology that could extend human lifespan by decades and automate half of white‑collar work within the next...
Wikipedia, Media Bias and AI with Jimmy Wales
In this episode, Wikipedia founder Jimmy Wales reflects on the platform’s 25‑year journey from a distrusted newcomer to a cornerstone of online knowledge, and he examines how AI—especially large language models—might reshape the way we access and trust information. Wales...